Exploring the Parameter Space of High Frequency Magnetic Perturbation in Manipulating Neural Excitability and Plasticity.
- Institution
- MAGNETIC TIDES, INC., CA
- Principal investigator
- Ludovica Labruna
- Funding
- $50K
- Duration
- 2024–2026
Moonbase score
Still being scored
Abstract
Project Summary/Abstract The kTMP electric field, which may be amplitude-modulated, couples with brain neurons to modify neuronal dynamics. To simultaneously record EEG signals while administering kTMP, the head coil must be brought in close proximity to the EEG electrodes. As a result, the EEG recordings could be contaminated with a high- amplitude 2-5 kHz component with amplitude modulation sidebands. Ideally, the kTMP signals can be removed from the EEG signal by digital low-pass filtering. We have encountered a non-ideal behavior in our combined kTMP and EEG system: Discrete peaks in the 0-100 Hz range have arisen in our EEG recordings that obfuscate the observation of changes to EEG signals in that same range. Tests to-date indicate that the EEG amplifier is likely the source of the artifacts. We are seeking TABA funds to remove these artifacts at the hardware level by building an analog low-pass filter bank for the EEG amplifier and a high-pass filter for the kTMP high-current amplifier.
LOADING MOONBASE SCORE
Questions for Magnetic Tides, Inc.
Magnetic Tides, Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same topic, scored first.
- NIH · Magnetic Tides, Inc.Not yet scored
Non-invasive brain stimulation using two-coil kTMP: simultaneous stimulation at two cortical targets and deep brain stimulation at a single target
Ludovica Labruna · $558K · 2025–2026
- NIH · Magnetic Tides, Inc.Not yet scored
A novel method of non-invasive brain stimulation to enhance motor function in chronic stroke patients
Ludovica Labruna · $937K · 2025–2028
- NIH · Magnetic Tides, Inc.Not yet scored
Efficacy of kTMP, a novel non-invasive brain stimulation method, for the treatment of anhedonia patients.
Ludovica Labruna · $1.7M · 2025–2028